2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
暂无分享,去创建一个
Eric L. Johnson | Raveendhara R. Bannuru | K. Khunti | R. Gabbay | R. Pratley | V. Aroda | Diana M. Isaacs | R. Bannuru | R. Stanton | P. Prahalad | M. Hilliard | F. Brown | J. Seley | S. Kahan | G. Aleppo | Jose Leon | S. Lyons | M. L. Perry | B. Collins | Dennis Bruemmer | Nuha A. ElSayed | Priya Prahalad | Grazia Aleppo
[1] I. Hirsch,et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2021, Diabetes Care.
[2] S. Saydah,et al. Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study , 2021, Diabetes Care.
[3] A. Jatoi,et al. Rare Adverse Events with Programmed Death-1 and Programmed Death-1 Ligand Inhibitors: Justification and Rationale for a Systematic Review , 2021, Current Oncology Reports.
[4] A. Dyer,et al. One Step or Two Step Testing for Gestational Diabetes: Which Is Best? , 2021, American journal of obstetrics and gynecology.
[5] David Alfego,et al. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis , 2021, PloS one.
[6] N. T. Dung,et al. Serum hs-CRP measured prior transplantation predicts of new-onset diabetes after transplantation in renal transplant recipients. , 2021, Transplant immunology.
[7] B. Marks,et al. Post-Transplantation Diabetes Mellitus in Pediatric Patients , 2021, Hormone Research in Paediatrics.
[8] J. Buse,et al. Carbohydrate Intake Prior to Oral Glucose Tolerance Testing , 2021, Journal of the Endocrine Society.
[9] Cheng-Chang Lu,et al. Hemoglobin A1c Levels Associated with Age and Gender in Taiwanese Adults without Prior Diagnosis with Diabetes , 2021, International journal of environmental research and public health.
[10] Shyang-Rong Shih,et al. Different cutoffs of hypertension, risk of incident diabetes and progression of insulin resistance: A prospective cohort study. , 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.
[11] Lee Ann Fullington,et al. HbA1c Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review , 2021, Preventing chronic disease.
[12] T. Hillier,et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. , 2021, The New England journal of medicine.
[13] K. Herold,et al. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals , 2021, Science Translational Medicine.
[14] E. Gregg,et al. Progression to diabetes by baseline glycemic status among middle-aged and older adults in the United States, 2006-2014. , 2021, Diabetes research and clinical practice.
[15] I. Beń-Skowronek. IPEX Syndrome: Genetics and Treatment Options , 2021, Genes.
[16] A. Dyer,et al. Newborn Adiposity and Cord Blood C-Peptide as Mediators of the Maternal Metabolic Environment and Childhood Adiposity , 2021, Diabetes Care.
[17] M. Petrov,et al. diagnosis of endocrine disease: Diagnosing and classifying diabetes in diseases of the exocrine pancreas. , 2021, European journal of endocrinology.
[18] D. Heimburger,et al. Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study , 2020, PloS one.
[19] M. Rewers,et al. Incidence and Predictors of Type 1 Diabetes among Younger Adults Aged 20-45 Years: The Diabetes in Young Adults (DiYA) Study. , 2020, Diabetes research and clinical practice.
[20] B. Chung,et al. Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial , 2020, Annals of transplantation.
[21] X. Bao,et al. Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review , 2020, Cancer Immunology, Immunotherapy.
[22] P. Ritz,et al. Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study , 2020, Obesity Surgery.
[23] K. Schechtman,et al. Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes. , 2020, The New England journal of medicine.
[24] Abdulaziz A. Alodhayani,et al. Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes , 2020, PloS one.
[25] R. Blackstone,et al. Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review , 2020, Current Obesity Reports.
[26] Krista K. Proia,et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review , 2020, Diabetes Care.
[27] M. McCarthy,et al. Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2020, Diabetes Care.
[28] Lauric A. Ferrat,et al. Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults , 2020, Diagnostic and Prognostic Research.
[29] Martin T. Wells,et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. , 2020, The lancet. Diabetes & endocrinology.
[30] Ming-Ju Wu,et al. Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study , 2020, International journal of environmental research and public health.
[31] R. Goland,et al. C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet , 2020, Diabetes Care.
[32] R. Mori,et al. Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review , 2020, Journal of epidemiology.
[33] M. Rewers,et al. Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado , 2020, Diabetes Care.
[34] R. Hummelen,et al. Early Gestational Diabetes Mellitus Screening With Glycated Hemoglobin: A Systematic Review. , 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[35] M. Monami,et al. Metabolic surgery for the treatment of type 2 diabetes: A network meta‐analysis of randomized controlled trials , 2020, Diabetes, obesity & metabolism.
[36] K. Khunti,et al. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes , 2020, BMJ Open Diabetes Research & Care.
[37] J. Nelson,et al. Reproducibility of a prediabetes classification in a contemporary population , 2020, Metabolism open.
[38] J. McNamara,et al. The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[39] Z. Nachum,et al. Markers for undiagnosed type 2 diabetes mellitus during pregnancy—A population‐based retrospective cohort study , 2020, Journal of diabetes.
[40] M. Mei-Zahav,et al. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[41] C. Y. Ooi,et al. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[42] E. Bonifacio,et al. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. , 2020, JAMA.
[43] Y. Bozkuş,et al. Analysis of Risk Factors for Posttransplant Diabetes Mellitus After Kidney Transplantation: Single-Center Experience. , 2020, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[44] A. Hattersley,et al. De Novo Mutations in EIF2B1 Affecting eIF2 Signaling Cause Neonatal/Early-Onset Diabetes and Transient Hepatic Dysfunction , 2019, Diabetes.
[45] P. W. Wilson,et al. Impact of mismatches in HbA1c vs glucose values on the diagnostic classification of diabetes and prediabetes , 2019, Diabetic medicine : a journal of the British Diabetic Association.
[46] Tao Yang,et al. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function , 2019, Diabetes & metabolism journal.
[47] S. Saghafian,et al. Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus. , 2019, The American journal of cardiology.
[48] S. K. Puri,et al. Dental clinic: Potential source of high-risk screening for prediabetes and type 2 diabetes , 2019, Indian journal of dental research : official publication of Indian Society for Dental Research.
[49] L. Pyle,et al. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010–2017 , 2019, Diabetes Care.
[50] Huixia Yang,et al. Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China , 2019, PLoS medicine.
[51] B. Shields,et al. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years , 2019, BMJ Open.
[52] P. McKeigue,et al. Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes , 2019, BMC Medicine.
[53] J. Egan,et al. Post-transplant diabetes mellitus associated with heart and lung transplant , 2019, Irish Journal of Medical Science (1971 -).
[54] I. Godsland,et al. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: an ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) Study Analysis. , 2019, Diabetes research and clinical practice.
[55] S. Mudaliar,et al. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? , 2019, Diabetologia.
[56] J. Krischer,et al. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. , 2019, The New England journal of medicine.
[57] L. Philipson,et al. GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants. , 2019, Diabetes research and clinical practice.
[58] Angela M Rodrigues,et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. , 2019, The lancet. Diabetes & endocrinology.
[59] B. Shields,et al. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes , 2019, Diabetologia.
[60] D. Nathan,et al. Accuracy of a Point-of-Care Hemoglobin A1c Assay , 2019 .
[61] D. Benaiges,et al. Association of first-trimester HbA1c levels with adverse pregnancy outcomes in different ethnic groups. , 2019, Diabetes research and clinical practice.
[62] M. Skopkova,et al. Novel insights into genetics and clinics of the HNF1A-MODY , 2019, Endocrine regulations.
[63] L. Barbour,et al. Universal early pregnancy glycosylated hemoglobin A1c as an adjunct to Carpenter-Coustan screening: an observational cohort study. , 2019, American journal of obstetrics & gynecology MFM.
[64] J. Gilmour. Response to the Letter to the Editor From Dr. Boudreau et al, "Validation of a Stepwise Approach Using Glycated Hemoglobin Levels to Reduce the Number of Required Oral Glucose Tolerance Tests to Screen for Cystic Fibrosis-Related Diabetes in Adults". , 2019, Canadian journal of diabetes.
[65] E. Etchells,et al. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels. , 2019, Canadian journal of diabetes.
[66] K. Vehik,et al. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children , 2019, Pediatric diabetes.
[67] A. Dyer,et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism , 2019, Diabetes Care.
[68] A. Dyer,et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism , 2019, Diabetes Care.
[69] S. Shortreed,et al. Early Pregnancy Hemoglobin A1C and Pregnancy Outcomes: A Population-Based Study , 2018, American Journal of Perinatology.
[70] N. White,et al. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association , 2018, Diabetes Care.
[71] T. Masui,et al. Current state and future evolution of pancreatic islet transplantation , 2018, Annals of gastroenterological surgery.
[72] C. Acerini,et al. ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis‐related diabetes in children and adolescents , 2018, Pediatric diabetes.
[73] G. Saccone,et al. Screening for gestational diabetes mellitus: one step versus two step approach. A meta-analysis of randomized trials , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[74] A. Dyer,et al. Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity , 2018, JAMA.
[75] S. Grant,et al. A Global Perspective of Latent Autoimmune Diabetes in Adults , 2018, Trends in Endocrinology & Metabolism.
[76] D. Simmons,et al. Ethnic Disparities in Gestational Diabetes , 2018, Current Diabetes Reports.
[77] Mark S. Anderson,et al. Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors , 2018, Diabetes.
[78] J. Coresh,et al. Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes , 2018, Annals of Internal Medicine.
[79] J. Crandell,et al. Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control Among Women of Reproductive Age. , 2018, Journal of women's health.
[80] J. Shaw,et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.
[81] J. Eriksson,et al. Effects of a Lifestyle Intervention During Pregnancy and First Postpartum Year: Findings From the RADIEL Study , 2018, The Journal of clinical endocrinology and metabolism.
[82] E. Mayer-Davis,et al. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study , 2018, Diabetes Care.
[83] Denise V. D’Angelo,et al. Disparities in Preconception Health Indicators — Behavioral Risk Factor Surveillance System, 2013–2015, and Pregnancy Risk Assessment Monitoring System, 2013–2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.
[84] Roy Taylor,et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial , 2017, The Lancet.
[85] J. Catov,et al. Early Pregnancy Diabetes Screening and Diagnosis: Prevalence, Rates of Abnormal Test Results, and Associated Factors. , 2017, Obstetrics and gynecology.
[86] D. Simmons,et al. Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysis , 2017, Current Diabetes Reports.
[87] R. Buzzetti,et al. Adult-onset autoimmune diabetes: current knowledge and implications for management , 2017, Nature Reviews Endocrinology.
[88] Christian Gieger,et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis , 2017, PLoS Medicine.
[89] A. Paterson. HbA1c for type 2 diabetes diagnosis in Africans and African Americans: Personalized medicine NOW! , 2017, PLoS medicine.
[90] Simon de Lusignan,et al. Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study , 2017, Diabetes Care.
[91] E. Barrett-Connor,et al. Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS) , 2017, Diabetic medicine : a journal of the British Diabetic Association.
[92] J. Wyckoff,et al. Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes , 2017, Current Diabetes Reports.
[93] E. Dirinck,et al. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population , 2017, International Journal of Obesity.
[94] R. Beck,et al. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. , 2017, Annals of internal medicine.
[95] B. Shields,et al. Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients , 2017, Diabetes Care.
[96] A. Avogaro,et al. SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System , 2017, Diabetologia.
[97] M. Korc,et al. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer , 2017, Diabetes.
[98] K. Guelfi,et al. A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women , 2017, American journal of obstetrics and gynecology.
[99] R. Ozaki,et al. In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring , 2017, Diabetes Care.
[100] Vikesh K. Singh,et al. Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation. , 2017, The Journal of clinical endocrinology and metabolism.
[101] A. Reiner,et al. Association of Sickle Cell Trait With Hemoglobin A1c in African Americans , 2017, JAMA.
[102] Emma English,et al. Performance of point-of-care HbA1c test devices: implications for use in clinical practice – a systematic review and meta-analysis , 2017, Clinical chemistry and laboratory medicine.
[103] A. Ferrara,et al. Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996–2014 , 2017, American journal of obstetrics and gynecology.
[104] E. Bonifacio,et al. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis , 2016, Diabetes.
[105] C. Bellanné-Chantelot,et al. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for? , 2016, Canadian journal of diabetes.
[106] J. Saunders,et al. Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria. , 2016, European journal of endocrinology.
[107] J. Makuc. Management of pancreatogenic diabetes: challenges and solutions , 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.
[108] Heejung Bang,et al. Comparison of screening scores for diabetes and prediabetes. , 2016, Diabetes research and clinical practice.
[109] E. Selvin. Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference , 2016, Diabetes Care.
[110] W. Herman. Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm! , 2016, Diabetes Care.
[111] M. S. Kirkman,et al. Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions , 2016, Diabetes Care.
[112] B. Shields,et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes , 2016, Diabetes Care.
[113] M. Molitch,et al. Diabetes Care After Transplant: Definitions, Risk Factors, and Clinical Management. , 2016, The Medical clinics of North America.
[114] L. Palaniappan,et al. First Trimester Hemoglobin A1c Prediction of Gestational Diabetes , 2016, American Journal of Perinatology.
[115] L. Philipson,et al. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated , 2016, Acta Diabetologica.
[116] K. Khunti,et al. Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.
[117] Lorie M. Harper,et al. Carpenter-Coustan Compared With National Diabetes Data Group Criteria for Diagnosing Gestational Diabetes , 2016, Obstetrics and gynecology.
[118] G. Umpierrez,et al. Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia , 2016, Nature Reviews Endocrinology.
[119] R. Tamler,et al. HYPERGLYCEMIA MANAGEMENT IN PATIENTS WITH POSTTRANSPLANTATION DIABETES. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[120] V. Gebski,et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus , 2016, BMJ Open.
[121] W. Herman,et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. , 2016, American journal of obstetrics and gynecology.
[122] J. Larsen,et al. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes , 2016 .
[123] S. Grant,et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema , 2016, Diabetes Care.
[124] Lyn Yasumura,et al. Gestational Diabetes Screening: The International Association of the Diabetes and Pregnancy Study Groups Compared With Carpenter-Coustan Screening , 2016, Obstetrics and gynecology.
[125] D. Feig,et al. Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy , 2015, Diabetes Care.
[126] Å. Lernmark,et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association , 2015, Diabetes Care.
[127] L. Geiss,et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.
[128] A. Hattersley,et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study , 2015, The Lancet.
[129] A. Hartmann,et al. Emerging treatments for post-transplantation diabetes mellitus , 2015, Nature Reviews Nephrology.
[130] N. Wintfeld,et al. Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy , 2015, Diabetes/metabolism research and reviews.
[131] J. Gross,et al. Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[132] Kamlesh Khunti,et al. Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) , 2015, Diabetes Care.
[133] M. Rewers,et al. Incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado youth, 1998-2012. , 2015, JAMA.
[134] A. Abacı,et al. Maturity-onset diabetes of the young (MODY): an update , 2015, Journal of pediatric endocrinology & metabolism : JPEM.
[135] E. Barrett-Connor,et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. , 2015, The Journal of clinical endocrinology and metabolism.
[136] Jeremy B Sussman,et al. Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program , 2015, BMJ : British Medical Journal.
[137] S. Kahn,et al. Optimum BMI Cut Points to Screen Asian Americans for Type 2 Diabetes , 2015, Diabetes Care.
[138] E. Bonifacio,et al. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) , 2015, Diabetes Care.
[139] Morton B. Brown,et al. Screening for prediabetes and type 2 diabetes in dental offices , 2015, Journal of public health dentistry.
[140] T. Brown,et al. Diagnosing and managing diabetes in HIV-infected patients: current concepts. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[141] N. Melamed,et al. The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. , 2015, American journal of obstetrics and gynecology.
[142] W. Fujimoto,et al. BMI Cut Points to Identify At-Risk Asian Americans for Type 2 Diabetes Screening , 2014, Diabetes Care.
[143] M. Rice,et al. Mild Gestational Diabetes Mellitus and Long-Term Child Health , 2014, Diabetes Care.
[144] S. Fowler,et al. HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial , 2014, Diabetes Care.
[145] D. Lauderdale,et al. Reconsidering the age thresholds for type II diabetes screening in the U.S. , 2014, American journal of preventive medicine.
[146] J. Rowan,et al. An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes , 2014, Diabetes Care.
[147] P. Catalano,et al. Perinatal Outcomes Associated With the Diagnosis of Gestational Diabetes Made by The International Association of the Diabetes and Pregnancy Study Groups Criteria , 2014, Obstetrics and gynecology.
[148] A. Hattersley,et al. The diagnosis and management of monogenic diabetes in children and adolescents , 2014 .
[149] G. Pacini,et al. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[150] D. Feig,et al. Trends in Incidence of Diabetes in Pregnancy and Serious Perinatal Outcomes: A Large, Population-Based Study in Ontario, Canada, 1996–2010 , 2014, Diabetes Care.
[151] Jasmin Divers,et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.
[152] P. Heneberg,et al. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[153] A. Åsberg,et al. Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[154] N. Emanuele,et al. The association between glycemic control and clinical outcomes after kidney transplantation. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[155] A. Tura,et al. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? , 2014, Acta Diabetologica.
[156] K. Vehik,et al. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease , 2014, Pediatric diabetes.
[157] K. Alberti,et al. Diagnosis and Classification of Diabetes Mellitus , 2013, Diabetes Care.
[158] Aaron N. Winn,et al. Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications , 2013, Diabetes Care.
[159] J. Coresh,et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes , 2013, Diabetes Care.
[160] A. Moran,et al. New insights into cystic fibrosis-related diabetes in children. , 2013, The lancet. Diabetes & endocrinology.
[161] I. Lamster,et al. Dental Findings and Identification of Undiagnosed Hyperglycemia , 2013, Journal of dental research.
[162] A. Tura,et al. Glucose Metabolism After Renal Transplantation , 2013, Diabetes Care.
[163] J. Krischer,et al. The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients , 2013, Diabetes Care.
[164] E. Bonifacio,et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.
[165] A. Hattersley,et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. , 2013, The Journal of clinical endocrinology and metabolism.
[166] F. Luan,et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[167] Nan Li,et al. Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China , 2013, Diabetes Care.
[168] L. Phillips,et al. Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk , 2013, Diabetes Care.
[169] F. Kaufman,et al. Diabetes Screening With Hemoglobin A1c Versus Fasting Plasma Glucose in a Multiethnic Middle-School Cohort , 2013, Diabetes Care.
[170] P. Zeitler,et al. Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children , 2012, International Journal of Pediatric Endocrinology.
[171] F. Tinahones,et al. Hemoglobin A1c Versus Oral Glucose Tolerance Test in Postpartum Diabetes Screening , 2012, Diabetes Care.
[172] C. Beam,et al. Fall in C-Peptide During First 2 Years From Diagnosis , 2012, Diabetes.
[173] J. Vendrell,et al. The usefulness of HbA1c in postpartum reclassification of gestational diabetes , 2012, BJOG : an international journal of obstetrics and gynaecology.
[174] T. Hannon,et al. Using hemoglobin A1c for prediabetes and diabetes diagnosis in adolescents: can adult recommendations be upheld for pediatric use? , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[175] C. K. Kwan,et al. Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals. , 2012, AIDS patient care and STDs.
[176] J. Ilonen,et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk , 2012, Diabetologia.
[177] A. Dyer,et al. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria , 2012, Diabetes Care.
[178] E. Bonifacio,et al. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes , 2012, Diabetologia.
[179] S. Wiegand,et al. Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. , 2011, Diabetes research and clinical practice.
[180] C. Haire,et al. Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. , 2011, Transplantation.
[181] L. Philipson,et al. Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment , 2011, Current diabetes reports.
[182] Peter C. Austin,et al. Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.
[183] I. Lamster,et al. Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting , 2011, Journal of dental research.
[184] Elizabeth Selvin,et al. Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.
[185] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[186] K. Robinson,et al. Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.
[187] D. Williamson,et al. A1C Level and Future Risk of Diabetes: A Systematic Review , 2010, Diabetes Care.
[188] Viola Vaccarino,et al. Glucose-Independent, Black–White Differences in Hemoglobin A1c Levels , 2010, Annals of Internal Medicine.
[189] Anil Bhansali,et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. , 2010, The Journal of clinical endocrinology and metabolism.
[190] B. Shields,et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.
[191] Justin Feigelman,et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.
[192] H. Bastian,et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[193] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[194] B. Shields,et al. Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[195] E. Ford,et al. Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.
[196] W. Herman,et al. Association Between Iron Deficiency and A1C Levels Among Adults Without Diabetes in the National Health and Nutrition Examination Survey, 1999–2006 , 2010, Diabetes Care.
[197] Dwight J Rouse,et al. A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.
[198] Jeffrey P. Krischer,et al. Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 , 2009, Diabetes Care.
[199] A. Hattersley,et al. The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.
[200] J. Pilewski,et al. Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia , 2009, Diabetes Care.
[201] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[202] Patrick E. Georgoff,et al. A1C Underestimates Glycemia in HIV Infection , 2009, Diabetes Care.
[203] B. Wolffenbuttel,et al. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.
[204] Kunam S Reddy,et al. Hyperglycemia during the immediate period after kidney transplantation. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[205] Bengt Persson,et al. Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .
[206] Renu Joshi,et al. Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[207] S. Fowler,et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. , 2008, The Journal of clinical endocrinology and metabolism.
[208] C. Hampe,et al. Syndromes of ketosis-prone diabetes mellitus. , 2008, Endocrine reviews.
[209] M. Cappellini,et al. Glucose-6-phosphate dehydrogenase deficiency , 2008, The Lancet.
[210] John M. Lachin,et al. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .
[211] A. Sharif,et al. The Use of Oral Glucose Tolerance Tests to Risk Stratify for New-Onset Diabetes After Transplantation: An Underdiagnosed Phenomenon , 2006, Transplantation.
[212] Jeannie S. Huang,et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[213] E. Hannan,et al. Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.
[214] W. Herman,et al. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.
[215] P. Luther,et al. Pioglitazone in the Management of Diabetes Mellitus after Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[216] P. Raskin,et al. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. , 2004, Archives of internal medicine.
[217] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[218] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[219] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[220] D. Eckland,et al. The pharmacokinetics of pioglitazone in patients with impaired renal function. , 2003, British journal of clinical pharmacology.
[221] W. Herman,et al. Community-based screening for diabetes in Michigan. , 2003, Diabetes care.
[222] Catherine Kim,et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.
[223] M. Schambelan,et al. Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV‐1 Infection: Recommendations of an International AIDS Society‐USA Panel , 2002, Journal of acquired immune deficiency syndromes.
[224] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[225] Merlin C. Thomas,et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. , 2001, Transplantation.
[226] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[227] Merlin C. Thomas,et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes , 2000, BMC nephrology.
[228] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[229] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[230] C. Férec,et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. , 1996, Human molecular genetics.
[231] D. Coustan,et al. Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.
[232] Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.
[233] H. L. Wilkerson,et al. The Effect of Prior Carbohydrate Intake on the Oral Glucose Tolerance Test , 1960, Diabetes.
[234] J. Conn. Interpretation of the glucose tolerance test. The necessity of a stand ard preparatory diet. , 1940 .
[235] Lara Frommer,et al. Autoimmune Polyendocrinopathy. , 2019, The Journal of clinical endocrinology and metabolism.
[236] Atypical Diabetes: Pathophysiology, Clinical Presentations, and Treatment Options , 2018 .
[237] ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. , 2018, Obstetrics and gynecology.
[238] P. Reix,et al. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard? , 2017, Journal of pediatric endocrinology & metabolism : JPEM.
[239] J. Gibney,et al. The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis , 2017, European Journal of Clinical Nutrition.
[240] L. Philipson,et al. A Clinical Guide to Monogenic Diabetes , 2016 .
[241] Betty C. Jung,et al. [Gestational Diabetes]. , 2016, Journal of midwifery & women's health.
[242] M. Rickels,et al. Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop. , 2015, Annals of surgery.
[243] Cuilin Zhang,et al. International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China , 2014, Chinese medical journal.
[244] Joyce M Lee,et al. Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. , 2013, JAMA pediatrics.
[245] D. Williamson,et al. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006. , 2011, American journal of preventive medicine.
[246] K. Khunti,et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. , 2011, Lancet.
[247] E. Lenters-Westra,et al. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. , 2010, Clinical chemistry.
[248] E. Gale. Declassifying diabetes , 2006, Diabetologia.
[249] A. Stolfi,et al. Insulin and oral agents for managing cystic fibrosis-related diabetes. , 2005, The Cochrane database of systematic reviews.
[250] SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. , 2004, Controlled clinical trials.
[251] C. Mahan,et al. CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. , 1964, Diabetes.